← Feed

ROBINS CHAD M

SEC Form 4 insider
CEO and Chairman · Adaptive Biotechnologies Corp ($ADPT)
1 thesis · first seen Aug 20, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ADPTSEC Form 4bearish
ROBINS CHAD M · CEO and Chairman at Adaptive Biotechnologies Corp · 5h agono track record yet
Sold 600,000 @ $24.80 avg · $14,882,166 · 2026-08-17

Form 4: ROBINS CHAD M sold ADPT

ROBINS CHAD M (CEO and Chairman at Adaptive Biotechnologies Corp) reported an open-market sale of 600,000 shares of ADPT at an average $24.80, roughly $14,882,166, in a Form 4 filed 2026-08-19.

View filing on SEC.gov →

End of results.